Ring‐Contracted Artemisinin Derivatives as Novel CDK 4/6 Inhibitors: Synthesis and Anti‐Breast Cancer Evaluation
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202400086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Jun-Jie Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 6, Artemisinins, Cyclin-Dependent Kinase 4, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Guizhou University Cultivation Project, Guizhou Provincial Science and Technology Foundation.
Abstract (Originalsprache)
The endoperoxide group of artemisinins is universally accepted an essential group for their anti‐cancer effects. In this study, a series of D‐ring‐contracted artemisinin derivatives were constructed by combining ring‐contracted artemisinin core with fragments of functional heterocyclic molecules or classical CDK4/6 inhibitors to identify more efficacious breast cancer treatment agents. Twenty‐six novel hybridized molecules were synthesized and characterized by HRMS, IR, 1 H‐NMR and 13 C NMR. In antiproliferative activities and kinase inhibitory effects assays, we found that the antiproliferative effects of B01 were close to those of the positive control Palbociclib, with GI 50 values of 4.87±0.23 μM and 9.97±1.44 μM towards T47D cells and MDA‐MB‐436 cells respectively. In addition, the results showed that B01 was the most potent compound against CDK6/cyclin D3 kinase, with an IC 50 value of 0.135±0.041 μM, and its activity was approximately 1/3 of the positive control Palbociclib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guizhou University, 550025, Guiyang, China.
- Guizhou Engineering Laboratory for Synthetic Drugs, 550025, Guiyang, China.
- Technical Department of Criminal Investigation Branch, Deyang Police Office, 618000, Deyang, China.
ORCID-Profile: Hang Zhong
Förderung
- Guizhou University Cultivation Project
- Guizhou Provincial Science and Technology Foundation
Zitieren
APA
Zhu, J. J., Ai, Y., Wu, J. H., Zeng, C. G., Cui, Z., Zhang, Z. P., Zhu, J. Y., Wang, C. Q., & Zhong, H. (2024). Ring‐Contracted Artemisinin Derivatives as Novel CDK 4/6 Inhibitors: Synthesis and Anti‐Breast Cancer Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400086
Vancouver
Zhu JJ, Ai Y, Wu JH, Zeng CG, Cui Z, Zhang ZP, et al. Ring‐Contracted Artemisinin Derivatives as Novel CDK 4/6 Inhibitors: Synthesis and Anti‐Breast Cancer Evaluation. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400086
BibTeX
@article{Zhu2024,
author = {Zhu, Jun-Jie and Ai, Yi and Wu, Jun-Hui and Zeng, Chang-Guang and Cui, Zhen and Zhang, Zheng-Ping and Zhu, Jia-Yi and Wang, Chang-Qi and Zhong, Hang},
title = {Ring‐Contracted Artemisinin Derivatives as Novel CDK 4/6 Inhibitors: Synthesis and Anti‐Breast Cancer Evaluation},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202400086}
}
EUVIMED